19 hours ago · What big data means for patients, payers, and pharma . ... McKinsey&Company Report November 2015. 8 Like Comment Share. To view or add a comment, ... >> Go To The Portal
This issue of the Quarterly, available here as a PDF download, explores how companies can raise their digital capabilities, apply discipline to the innovation process, and more comprehensively guard against cyberattacks. Download the full issue of McKinsey Quarterly 2015 Number 3 (PDF–3.3MB).
Our Global Media Report 2015 offers both high-level data and a granular look at the media industry around the world. It provides annual historical data from 2009 through 2014, along with forecasts from 2015 through 2019, on a country-by-country basis, for 12 major media categories and numerous sub-categories.
They could be key to ushering in an era of exponential innovation in healthcare. Matthias Evers is a senior partner in McKinsey’s Hamburg office, Lucy Pérez is a senior partner in the Boston office, Lucas Robke is a consultant in the Düsseldorf office, and Katarzyna Smietana is a senior knowledge expert and associate partner in the Wroclaw office.
As might be expected, adherence rates varied noticeably among the disease categories examined. Exhibit 1 shows adherence and persistence rates across diseases.
In analyzing data that included prescription, healthcare, and consumer variables, we gained preliminary insight into the types of factors that may be influencing adherence, which may play a role in explaining differences seen among different medications.
Psoriasis had the lowest median persistence rate among the diseases studied and substantial variations in both persistence and adherence levels among medications. Many brands in this disease area are accompanied by patient-support programs.
These insights have practical business implications for pharmaceutical companies, healthcare systems, and health practitioners, including the following:
Pinpointing the factors across the four dimensions of nonadherence is necessary to effectively address patient adherence. By analyzing integrated data, pharmaceutical and healthcare companies can group patients into microsegments based on the different factors identified and design tailored interventions to support them.
Jason Hichborn is a specialist in McKinsey’s North American Knowledge Center; Sari Kaganoff is an associate partner in the New Jersey office, where Nisha Subramanian is a partner; and Ziv Yaar is a partner in the Boston office.
The big-data revolution in US health care: Accelerating value and innovation. Big data could transform the health-care sector, but the industry must undergo fundamental changes before stakeholders can capture its full value.
Meanwhile, the US federal government and other public stakeholders have been opening their vast stores of health-care knowledge, including data from clinical trials and information on patients covered under public insurance programs. In parallel, recent technical advances have made it easier to collect and analyze information from multiple ...
Over the last decade, pharmaceutical companies have been aggregating years of research and development data into medical databases, while payors and providers have digitized their patient records.
Physicians have traditionally used their judgment when making treatment decisions, but in the last few years there has been a move toward evidence-based medicine, which involves systematically reviewing clinical data and making treatment decisions based on the best available information.
After more than 20 years of steady increases, health-care expenses now represent 17.6 percent of GDP—nearly $600 billion more than the expected benchmark for a nation of the United States’s size and wealth. 1. 1.
Patients must be encouraged to play an active role in their own health by making the right choices about diet, exercise, preventive care, and other lifestyle factors. Right care. Patients must receive the most timely, appropriate treatment available.
Patients will not benefit from research on exercise, for example, if they persist in their sedentary lifestyles.